Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicles may soon be used more for targeted and systemic drug delivery.

Frequent use of hair straighteners can cause hair loss similar to scarring alopecia in young Turkish women.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

The document suggests a rare skin condition might be caused by a genetic phenomenon.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Hair loss greatly affects quality of life, and dermatologists are crucial for proper diagnosis and treatment.

A thorough initial check-up is essential before sperm banking to ensure the best chance of preserving good quality sperm.

Hair loss in women is often due to hereditary conditions or stress, and while treatments like minoxidil can help, diagnosis and management require medical guidance.

Melatonin helps regulate hair growth and protects the hair follicle from stress.

Hyperprolactinemia should be treated before confirming a PCOS diagnosis.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Patients with schizophrenia have a high rate of skin diseases, with fungal infections and dermatitis being most common, and those on clozapine have a lower risk of fungal infections.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Women with PCOS have thicker parafoveal areas in their retinas, but their macular blood vessel density is normal.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Animals that change color with the seasons mainly do so in response to daylight changes, but climate change is causing camouflage problems that may require evolutionary changes.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Hair growth is influenced by various body and external factors, and neighboring hairs communicate to synchronize regeneration.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.